-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$17.50135.22% Upside
Kezar Life Sciences, Inc. Frequently Asked Questions
-
What analysts cover Kezar Life Sciences, Inc.?
Kezar Life Sciences, Inc. has been rated by research analysts at H.C. Wainwright, Wells Fargo in the past 90 days.